Literature DB >> 20547953

The prevalence of age-related macular degeneration and associated risk factors.

Ronald Klein1, Karen J Cruickshanks, Scott D Nash, Elizabeth M Krantz, F Javier Nieto, Guan H Huang, James S Pankow, Barbara E K Klein.   

Abstract

OBJECTIVES: To determine the prevalence of age-related macular degeneration (AMD) and to examine how retinal drusen, retinal pigmentary abnormalities, and early AMD are related to age, sex, and other risk factors. PARTICIPANTS: A total of 2810 people aged 21 to 84 years participating in the Beaver Dam Offspring Study.
METHODS: The presence and severity of various characteristics of drusen and other lesions typical of AMD were determined by grading digital color fundus images using the Wisconsin Age-Related Maculopathy Grading System.
RESULTS: Early AMD was present in 3.4% of the cohort and varied from 2.4% in those aged 21 to 34 years to 9.8% in those aged 65 years or older. In a multivariable model (expressed as odds ratio; 95% confidence interval), age (per 5 years of age, 1.22; 1.09-1.36), being male (1.65; 1.01-2.69), more pack-years of cigarettes smoked (1-10 vs 0, 1.31; 0.75-2.29; >or=11 vs 0, 1.67; 1.03-2.73), higher serum high-density lipoprotein cholesterol level (per 5 mg/dL, 0.91; 0.83-0.998), and hearing impairment (2.28; 1.41-3.71) were associated with early AMD. There were no associations of blood pressure level, body mass index, physical activity level, history of heavy drinking, white blood cell count, hematocrit level, platelet count, serum total cholesterol level, or carotid intimal-medial thickness with early AMD.
CONCLUSIONS: These data indicate that early AMD is infrequent before age 55 years but increases with age thereafter. Early AMD is related to modifiable risk factors, eg, smoking and serum high-density lipoprotein cholesterol level.

Entities:  

Mesh:

Year:  2010        PMID: 20547953      PMCID: PMC2896217          DOI: 10.1001/archophthalmol.2010.92

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  41 in total

1.  Increased atherogenic lipoproteins are associated with cognitive impairment: effects of statins and subclinical atherosclerosis.

Authors:  Cynthia M Carlsson; David M Nondahl; Barbara E K Klein; Patrick E McBride; Mark A Sager; Carla R Schubert; Ronald Klein; Karen J Cruickshanks
Journal:  Alzheimer Dis Assoc Disord       Date:  2009 Jan-Mar       Impact factor: 2.703

2.  Fifteen-year cumulative incidence of age-related macular degeneration: the Beaver Dam Eye Study.

Authors:  Ronald Klein; Barbara E K Klein; Michael D Knudtson; Stacy M Meuer; Maria Swift; Ronald E Gangnon
Journal:  Ophthalmology       Date:  2007-02       Impact factor: 12.079

3.  Cardiovascular risk factors and the long-term incidence of age-related macular degeneration: the Blue Mountains Eye Study.

Authors:  Jennifer S L Tan; Paul Mitchell; Wayne Smith; Jie Jin Wang
Journal:  Ophthalmology       Date:  2007-02-01       Impact factor: 12.079

4.  Emphysema, airflow limitation, and early age-related macular degeneration.

Authors:  Ronald Klein; Michael D Knudtson; Barbara E K Klein; Tien Y Wong; Mary Frances Cotch; Graham Barr
Journal:  Arch Ophthalmol       Date:  2010-04

5.  Hypertension, cardiovascular disease, and age-related macular degeneration. Age-Related Macular Degeneration Risk Factors Study Group.

Authors:  L Hyman; A P Schachat; Q He; M C Leske
Journal:  Arch Ophthalmol       Date:  2000-03

Review 6.  The role of oxidative stress in the pathogenesis of age-related macular degeneration.

Authors:  S Beatty; H Koh; M Phil; D Henson; M Boulton
Journal:  Surv Ophthalmol       Date:  2000 Sep-Oct       Impact factor: 6.048

7.  Age-period-cohort effect on the incidence of age-related macular degeneration: the Beaver Dam Eye Study.

Authors:  Ronald Klein; Michael D Knudtson; Kristine E Lee; Ronald E Gangnon; Barbara E K Klein
Journal:  Ophthalmology       Date:  2008-09       Impact factor: 12.079

8.  Measuring taste impairment in epidemiologic studies: the Beaver Dam Offspring Study.

Authors:  K J Cruickshanks; C R Schubert; D J Snyder; L M Bartoshuk; G H Huang; B E K Klein; R Klein; F J Nieto; J S Pankow; T S Tweed; E M Krantz; G S Moy
Journal:  Ann N Y Acad Sci       Date:  2009-07       Impact factor: 5.691

9.  Alcohol consumption and the 15-year cumulative incidence of age-related macular degeneration.

Authors:  Michael D Knudtson; Ronald Klein; Barbara E K Klein
Journal:  Am J Ophthalmol       Date:  2007-06       Impact factor: 5.258

10.  The prevalence of age-related maculopathy in the Rotterdam Study.

Authors:  J R Vingerling; I Dielemans; A Hofman; D E Grobbee; M Hijmering; C F Kramer; P T de Jong
Journal:  Ophthalmology       Date:  1995-02       Impact factor: 12.079

View more
  104 in total

1.  The role of anti-inflammatory agents in age-related macular degeneration (AMD) treatment.

Authors:  Y Wang; V M Wang; C-C Chan
Journal:  Eye (Lond)       Date:  2010-12-24       Impact factor: 3.775

Review 2.  Dry age-related macular degeneration: mechanisms, therapeutic targets, and imaging.

Authors:  Catherine Bowes Rickman; Sina Farsiu; Cynthia A Toth; Mikael Klingeborn
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-12-13       Impact factor: 4.799

3.  Associations between abnormal rod-mediated dark adaptation and health and functioning in older adults with normal macular health.

Authors:  Cynthia Owsley; Carrie Huisingh; Gregory R Jackson; Christine A Curcio; Alexander J Szalai; Nassrin Dashti; Mark Clark; Kia Rookard; Mark A McCrory; Tyler T Wright; Michael A Callahan; Lanning B Kline; C Douglas Witherspoon; Gerald McGwin
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-05-22       Impact factor: 4.799

4.  [Demography and age-dependency in ophthalmic diseases].

Authors:  C Wolfram
Journal:  Ophthalmologe       Date:  2015-01       Impact factor: 1.059

5.  Effects of chronic smoking on color vision in young subjects.

Authors:  Hatice Arda; G Ertugrul Mirza; Osman A Polat; Sarper Karakucuk; Ayse Oner; Koray Gumus
Journal:  Int J Ophthalmol       Date:  2015-02-18       Impact factor: 1.779

6.  The incidental findings of age-related macular degeneration during diabetic retinopathy screening.

Authors:  Rita Gangwani; Wico W Lai; Rita Sum; Sarah M McGhee; Catherine W S Chan; Anthony J Hedley; David Wong
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-11-27       Impact factor: 3.117

7.  Cholesterol crystals induce inflammatory cytokines expression in a human retinal pigment epithelium cell line by activating the NF-κB pathway.

Authors:  Yijun Hu; Haijiang Lin; Bernard Dib; Alp Atik; Peggy Bouzika; Christopher Lin; Yueran Yan; Shibo Tang; Joan W Miller; Demetrios G Vavvas
Journal:  Discov Med       Date:  2014 Jul-Aug       Impact factor: 2.970

Review 8.  Age-related macular degeneration: genetics and biology coming together.

Authors:  Lars G Fritsche; Robert N Fariss; Dwight Stambolian; Gonçalo R Abecasis; Christine A Curcio; Anand Swaroop
Journal:  Annu Rev Genomics Hum Genet       Date:  2014-04-16       Impact factor: 8.929

9.  Prevalence of intermediate-stage age-related macular degeneration in patients with acquired immunodeficiency syndrome.

Authors:  Douglas A Jabs; Mark L Van Natta; Efe Sezgin; Jeong Won Pak; Ronald Danis
Journal:  Am J Ophthalmol       Date:  2015-03-11       Impact factor: 5.258

10.  Risk alleles in CFH and ARMS2 and the long-term natural history of age-related macular degeneration: the Beaver Dam Eye Study.

Authors:  Ronald Klein; Chelsea E Myers; Stacy M Meuer; Ronald E Gangnon; Theru A Sivakumaran; Sudha K Iyengar; Kristine E Lee; Barbara E K Klein
Journal:  JAMA Ophthalmol       Date:  2013-03       Impact factor: 7.389

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.